Related Experiment Video

Updated: May 3, 2026

Generation of In-Frame Gene Deletion Mutants in Pseudomonas aeruginosa and Testing for Virulence Attenuation in a Simple Mouse Model of Infection
08:34

Generation of In-Frame Gene Deletion Mutants in Pseudomonas aeruginosa and Testing for Virulence Attenuation in a Simple Mouse Model of Infection

Published on: January 8, 2020

6.3K

Site-specific pegylation of an antimicrobial peptide increases resistance to Pseudomonas aeruginosa elastase

Chiara Falciani1, Luisa Lozzi, Silvia Scali

  • 1Dipartimento di Biotecnologie Mediche, Università di Siena, Siena, Italy.

Amino Acids
|February 11, 2014
PubMed

Insights

Pegylation of the M33 peptide enhances its stability against Pseudomonas aeruginosa elastase, a key bacterial virulence factor. This modification improves the potential of M33-Peg as a novel antibacterial drug candidate.

Area of Science:

  • Microbiology
  • Drug Discovery
  • Biochemistry

Background:

  • M33 is a branched peptide drug candidate for treating gram-negative bacterial infections.
  • Pseudomonas aeruginosa elastase is a critical virulence factor that degrades antimicrobial peptides.
  • Enhancing peptide stability against host proteases is crucial for drug efficacy.

Purpose of the Study:

  • To pegylate the M33 peptide at its C-terminus.
  • To evaluate the impact of pegylation on M33's stability against Pseudomonas aeruginosa elastase.
  • To assess the potential of pegylated M33 (M33-Peg) as an antibacterial agent.

Main Methods:

  • Chemical synthesis of pegylated M33 (M33-Peg).
  • In vitro assays measuring M33-Peg stability in the presence of purified Pseudomonas aeruginosa elastase.
  • Comparative analysis of M33 and M33-Peg stability.

Main Results:

  • Successful pegylation of the M33 peptide at the C-terminus.
  • Pegylated M33 demonstrated significantly increased stability against Pseudomonas aeruginosa elastase compared to native M33.
  • Enhanced stability suggests improved resistance to proteolytic degradation by a key bacterial virulence factor.

Conclusions:

  • Pegylation is a viable strategy to enhance the stability of the M33 peptide.
  • M33-Peg exhibits improved resistance to Pseudomonas aeruginosa elastase, a critical factor for its activity against Pseudomonas infections.
  • M33-Peg represents a promising candidate for further preclinical development as a novel antibacterial therapeutic.

More Related Videos

Mitigation of Blood Borne Cell Attachment to Metal Implants through CD47-Derived Peptide Immobilization08:13

Mitigation of Blood Borne Cell Attachment to Metal Implants through CD47-Derived Peptide Immobilization

Published on: December 3, 2020

3.7K
Production and Visualization of Bacterial Spheroplasts and Protoplasts to Characterize Antimicrobial Peptide Localization10:13

Production and Visualization of Bacterial Spheroplasts and Protoplasts to Characterize Antimicrobial Peptide Localization

Published on: August 11, 2018

12.1K

Related Concept Videos

Inhibitors of Gram-positive Cell Wall Synthesis01:23

Inhibitors of Gram-positive Cell Wall Synthesis

Bacterial cell walls are typically rigid structures composed mainly of peptidoglycan, a mesh-like polymer that provides mechanical strength and maintains cell shape. The synthesis of peptidoglycan is a crucial process in bacterial growth and serves as a primary target for many antibiotics.Mechanism of Action of Beta-Lactam AntibioticsBeta-lactam antibiotics, such as penicillin, inhibit peptidoglycan synthesis in actively growing cells. These antibiotics share a characteristic four-membered...
191
Gene Regulation in Microbial Communities: Quorum Sensing01:28

Gene Regulation in Microbial Communities: Quorum Sensing

Quorum sensing is a mechanism of bacterial communication that enables coordinated gene expression in response to changes in population density. This facilitates collective behaviors that enhance survival, resource acquisition, and ecological adaptation. This process relies on small signaling molecules called autoinducers that accumulate as bacterial populations grow. When a critical threshold concentration of autoinducers is reached, bacterial cells collectively modify gene expression,...
954
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within...
90
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and...
219
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
2.0K